Nationwide Children's News Releases
Viewing: 91-96 of 96 | All
Aug 30, 2005
Columbus Children's Hospital Researchers Prove Vagus Nerve Stimulation (VNS) is Effective in Treating Children With Epilepsy
Epilepsy, a brain disorder that occurs when the electrical signals in the brain are disrupted, affects about two million Americans. Most people with Epilepsy respond well to medication, but in approximately 25-30 percent of patients, medication doesn't work.
Jul 13, 2005
The Dangers of Mini Trampolines and Full-Sized Trampolines are Similar
Prior research has already proven the dangers of recreational full-sized trampoline use, but now a new study from researchers at Columbus Children’s Research Institute on the campus of Columbus Children’s Hospital has proven that injury patterns associated with mini trampolines
Jun 09, 2005
Vaccine Being Developed to Prevent Ear Infections in Children
Hoping to prevent ear infections for the more than 15 million children in the United States who suffer from them, a promising new vaccine candidate to prevent middle ear infections (otitis media) is being developed by researchers at the Columbus Children’s Research Institute (CCRI) on the
May 03, 2005
Columbus Children's Hospital Leads First National Muscular Dystrophy Newborn Screening Study
Columbus Children’s Research Institute (CCRI) at Columbus Children’s Hospital recently received a grant from the Centers for Disease Control to develop and implement a newborn screening trial for Duchenne muscular dystrophy, the most common type of muscular dystrophy in children.
Jan 01, 0001
Investigators Develop Technique to Effectively Edit NK Cells to Target Specific Cancer Cells
Originally, NK cells seemed promising for a natural therapy to fight cancer due to their innate ability to recognize any cells expressing stress or signs of infection. But investigators quickly realized they faced three key challenges: first, it was difficult to grow a large enough number of NK cells in the lab to offer useful infusions at a reasonable cost; second, an ideal universal donor solution was needed to make NK cell products faster, more reliably and with off-the-shelf availability; and third, NK cells were resistant to genetic modifications that might help them better target specific types of cancer cells. Nationwide Children’s Hospital investigators and their collaborators painstakingly solved the first two problems over the past decade. Now, they’ve conquered the third.
Jan 01, 0001
A Single-Dose Cancer Immunotherapy via Gene Transfer
Researchers at Nationwide Children’s Hospital report proof-of-principle results for a new gene therapy cancer treatment. The off-the-shelf, single-dose immunotherapy serves as an alternative to CAR-T therapy and can be engineered to be on-demand.